James Connor Kelly - 11 Apr 2023 Form 3 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
Director
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
11 Apr 2023
Net transactions value
$0
Form type
3
Filing time
20 Apr 2023, 19:16:26 UTC

No securities are beneficially owned.